Kyle Schwarber continues his amazing hot streak with eight home runs in five games
The hottest hitter in baseball right now? There's no question it's Kyle Schwarber of the Washington Nationals.
The outfielder and recently installed leadoff hitter began Thursday night's game in Miami with – what else – a home run. It marked the fifth time he's led off with a homer in his past 12 games.
Then in the second inning, Schwarber came up again and drilled an 0-2 pitch to dead center field for a three-run homer.
Schwarber has now hit eight home runs in his last five games – and since moving into the leadoff spot in the order on June 12, he's hit 12 dingers in his last 13 games.
ANOTHER! @kschwarb12 is on pace for 9 homers tonight! 😱 pic.twitter.com/SX7FfKqxqB
Schwarber now has 21 home runs on the season – two in April, seven in May and now 12 in June.
The Nationals team record for the most home runs in any month is 13 by Bryce Harper in May 2015.
Looks like the reigning National League Player of the Week might be the early favorite for the award yet again.
FDA Authorizes Genentech’s Actemra To Treat Hospitalized COVID-19 Patients
Genentech, a member of the Roche Group (RHHBY), said Thursday that its Actemra or tocilizumab has received an emergency use authorization from the U.S. Food and Drug Administration for the treatment of COVID-19 in hospitalized adults and pediatric patients (2 years of age and older) who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation or ECMO.
The authorization is based on results from four randomized, controlled studies that evaluated Actemra for the treatment of COVID-19 in more than 5,500 hospitalized patients. The results of these studies suggested that Actemra may improve outcomes in patients receiving corticosteroids and requiring supplemental oxygen or breathing support.
Actemra is not authorized for use in outpatients with COVID-19.
China's Bitmain suspends sales of cryptomining machines after Beijing's mining ban
SHANGHAI (Reuters) – Bitmain, China’s biggest maker of cryptocurrency mining machines, said it had suspended sales of its products in the spot market to help ease selling pressure on the secondary market following Beijing’s ban on bitcoin mining.
In a statement, Bitmain said it is looking for “quality” power supplies overseas along with its clients.
Hawks’ Trae Young has a fan in Reggie Miller: ‘People say borderline cocky. I don’t mind that’
MILWAUKEE – Atlanta’s Trae Young made one of his long 3-pointers in the third quarter against Milwaukee and backpedaled to defend along the sideline at halfcourt right by TNT NBA analyst Reggie Miller.
There is poetic justice that TNT broadcasts the Eastern Conference finals this season because that gives Miller a courtside view of Young who led the Hawks to a 116-113 victory in Game 1 on Wednesday.
Game recognizes game.
“It’s his confidence, that’s what I love most about him,” Miller said. “People say borderline cocky. I don’t mind that. I like a guy who is confident in his skills. People have got to understand (what) it takes to be not only a professional athlete. But the skillset Trae has – the shooting, the dribbling, the tear drops, the floaters, the runners – that’s countless hours in the gym. I respect that because I’ve been there. I know that. There’s a lot of sacrifice that goes into that. I like the ego that he has. It’s something that’s fun to watch.”
Why Won’t Anyone Help Me in This Sex Shop?
At 83, and legally blind, I could use some assistance.
By Diana de Vegh
I didn’t see what the problem was. I’m a perfectly respectable woman who knows what she wants and has the ability to pay for it. At 83, I may be a little older than most, and legally blind, but generally speaking, people are pleased to welcome me into their shops and boutiques and promptly move forward to offer assistance.
Dye & Durham appoint JPMorgan, Scotiabank advisers for strategic review
June 24 (Reuters) – Dye & Durham Ltd said the special committee of its board has appointed JPMorgan and Scotiabank as its financial advisers in connection to a strategic review process in response to a buyout offer from a management-led shareholder group worth about C$3.4 billion ($2.76 billion).
The Canadian cloud-based software maker said in May a newly formed special committee of independent directors would explore and evaluate potential strategic alternatives, including a merger, the sale of the company or its parts, and the sale of some of its assets. ($1 = 1.2308 Canadian dollars)
Smiths Medical Recalls Certain Jelco Hypodermic Insulin Syringes
Medical devices supplier Smiths Medical, affiliated to Smiths Group plc, is recalling certain Jelco Hypodermic Needle-Pro Fixed Needle insulin syringes with skewed graduation markings, the U.S. Food and Drug Administration said.
The recall was initiated after the company became aware of specific models and lots of Jelco insulin syringes that may exhibit skewed odd number line graduation markings on their syringe barrels. The company has identified markings that skewed approximately 20 degrees upward.
As a result of this issue, there is potential for administration of an incorrect dose of insulin, which could result in hyperglycemia, which may lead to ketoacidosis, or hypoglycemia, which may lead to seizures. This may result in serious harm or death.
However, Smiths Medical has not received any reports of death or serious injury related to this issue to date.
The recall includes Jelco insulin syringe 28Gx1/2″ 1CC with model number 4428-1 and lot numbers 4046543 and 4062235.
The affected products also include Jelco insulin syringe 29Gx1/2″ 1CC with model number 4429-1, and lot numbers 4014096, 4031846, 4031845, 4040734, 4043536, 4046545, 4046546, 4062239, 4062240, 4062238 and 4062242.
The patients or caretakers are urged to contact the pharmacy, home healthcare provider or medical facility that provided the syringe to arrange for return of the syringe and replacement.